Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ARCT is expected to report earnings to fall 717.31% to $3.21 per share on August 11

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports

Q2'25

Est.

$3.21

Q1'25

Missed

by $4.11

Q4'24

Missed

by $0.92

Q3'24

Beat

by $0.31

Q2'24

Beat

by $0.38

The last earnings report on May 12 showed earnings per share of -51 cents, missing the estimate of $3.59. With 133.56K shares outstanding, the current market capitalization sits at 347.14M.

View a ticker or compare two or three

Compare

ARCT